Concepedia

Pim P. van de Donk

PP

5

Publications

286

Citations

5

H-Index

2020

Active since

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Leiden University Medical Center

Radboud University Medical Center

Radboud University Nijmegen

Pim P. van de Donk is an author at University Medical Center Groningen specializing in oncology, cancer therapeutics, and molecular oncology.

ORCID

Top concepts

Publications per year

2020–2022

5

Publications

5

Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

Laura Kist de Ruijter, Pim P. van de Donk, Jahlisa S. Hooiveld-Noeken et al. · Nature Medicine · 2022 · 112 citations · Full text

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

Iris C. Kok, J.S. Hooiveld, Pim P. van de Donk et al. · Annals of Oncology · 2021 · 84 citations · Full text

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy

Pim P. van de Donk, Thijs T. Wind, Jahlisa S. Hooiveld-Noeken et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 46 citations · Full text

<sup>89</sup>Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Sarah R. Verhoeff, Pim P. van de Donk, Erik H.J.G. Aarntzen et al. · Journal of Nuclear Medicine · 2022 · 33 citations · Full text

, , +15

<sup>89</sup>Zr-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.

Sarah R. Verhoeff, Pim P. van de Donk, Erik H.J.G. Aarntzen et al. · Journal of Clinical Oncology · 2020 · 11 citations · Full text

, , +22

Rows per page

1–5 of 5